1. Home
  2. RANI vs STIM Comparison

RANI vs STIM Comparison

Compare RANI & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.68

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.76

Market Cap

88.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RANI
STIM
Founded
2012
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.9M
88.4M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
RANI
STIM
Price
$0.68
$1.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$7.50
$3.00
AVG Volume (30 Days)
634.8K
1.3M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
57.14
57.25
EPS
N/A
N/A
Revenue
$1,633,000.00
$52,776,000.00
Revenue This Year
$274.77
$11.10
Revenue Next Year
$79.44
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
58.85
N/A
52 Week Low
$0.39
$0.80
52 Week High
$3.87
$4.84

Technical Indicators

Market Signals
Indicator
RANI
STIM
Relative Strength Index (RSI) 35.15 70.44
Support Level $0.45 $1.21
Resistance Level $0.83 $2.13
Average True Range (ATR) 0.05 0.14
MACD -0.00 0.05
Stochastic Oscillator 20.70 89.31

Price Performance

Historical Comparison
RANI
STIM

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: